AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29660351 — intervention group
Group type: EXPERIMENTAL
Intervention: Low hemoglobin
Number of subjects: 7513
Study 27067394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonidegib 200 mg
Number of subjects: 94
Study 27067394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonidegib 800 mg
Number of subjects: 94
Study 24814043 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 4-hour interactive training sessions for nursing staff on appropriate medication treatment
Number of subjects: 227
Study 24814043 — intervention group
Group type: COMPARATOR
Intervention: Routine care without additional training (control group)
Number of subjects: 227
Study 24814043 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 4-hour interactive training sessions for nursing staff
Number of subjects: 227
Study 23136158 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 385
Study 23136158 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 385
Study 19606374 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 82
Study 19606374 — intervention group
Group type: COMPARATOR
Intervention: Obese children
Number of subjects: 82
Study 19606374 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 82
Study 19606374 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin associations
Number of subjects: 82
Study 18606286 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation Test (novice drivers)
Number of subjects: 434
Study 18606286 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation Test (unsafe drivers and overconfident drivers)
Number of subjects: 434
Study 18606286 — intervention group
Group type: COMPARATOR
Intervention: Adaptation Test (experienced drivers)
Number of subjects: 434
Study 15723732 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 1403
Study 15723732 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 4-mg nicotine lozenge
Number of subjects: 1403
Study 15723732 — intervention group
Group type: COMPARATOR
Intervention: Placebo (patch)
Number of subjects: 1403
Study 15723732 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lozenge)
Number of subjects: 1403
Study 11952054 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light-Caffeine
Number of subjects: 11
Study 11952054 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light-Placebo
Number of subjects: 11
Study 11952054 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim Light-Caffeine
Number of subjects: 11
Study 11952054 — intervention group
Group type: COMPARATOR
Intervention: Dim Light-Placebo
Number of subjects: 11
Study 11952054 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light (3000 lx)
Number of subjects: 11
Study 11952054 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg)
Number of subjects: 11
Study 10069753 — intervention group
Group type: EXPERIMENTAL
Intervention: Inconsistent responses from male adolescents
Number of subjects: 0
Study 10069753 — intervention group
Group type: EXPERIMENTAL
Intervention: Inconsistent responses from Black and Hispanic adolescents
Number of subjects: 0
Study 10069753 — intervention group
Group type: EXPERIMENTAL
Intervention: Living status and academic achievements
Number of subjects: 0
Study 7717837 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoprene chest belt
Number of subjects: 16
Study 7717837 — intervention group
Group type: COMPARATOR
Intervention: Webbing thigh belt
Number of subjects: 16
Study 7717837 — intervention group
Group type: COMPARATOR
Intervention: No belt
Number of subjects: 16
Study 7717837 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoprene chest belt (lower thoracic paraplegia)
Number of subjects: 16
Study 7717837 — intervention group
Group type: COMPARATOR
Intervention: Neoprene chest belt (able-bodied controls)
Number of subjects: 16
Study 1903907 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 66
Study 1903907 — intervention group
Group type: COMPARATOR
Intervention: No ultrasound
Number of subjects: 66
Study 31986290 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium-enriched salt substitute
Number of subjects: 20996
Study 31986290 — intervention group
Group type: COMPARATOR
Intervention: Usual salt
Number of subjects: 20996
Study 31986290 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 20996
Study 29985566 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (O3FA)
Number of subjects: 51
Study 29985566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 25694257 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (group 1, n = 197)
Number of subjects: 395
Study 25694257 — intervention group
Group type: COMPARATOR
Intervention: Intra-cervical Foley catheter plus vaginal isosorbide mononitrate (group 2, n = 198)
Number of subjects: 395
Study 25193793 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meal rich in LC n‐3 PUFA
Number of subjects: 78
Study 25193793 — intervention group
Group type: COMPARATOR
Intervention: Control meal (low in LC n‐3 PUFA and polyphenols)
Number of subjects: 78
Study 25193793 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meal rich in polyphenols and low in LC n‐3 PUFA
Number of subjects: 78
Study 25193793 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meal rich in both LC n‐3 PUFA and polyphenols
Number of subjects: 78
Study 22525651 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cold application (ice applied intermittently to one leg)
Number of subjects: 11
Study 22525651 — intervention group
Group type: COMPARATOR
Intervention: Control leg (no cold application)
Number of subjects: 11
Study 19822328 — intervention group
Group type: EXPERIMENTAL
Intervention: PWP condition (picture-word-picture)
Number of subjects: 2
Study 19822328 — intervention group
Group type: EXPERIMENTAL
Intervention: PWW condition (picture-word-word)
Number of subjects: 2
Study 19822328 — intervention group
Group type: COMPARATOR
Intervention: Noninterference control condition (P-W)
Number of subjects: 2
Study 18774895 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally proficient weight loss and weight loss maintenance program for black women (6-month weight loss program followed by a 1-year maintenance program)
Number of subjects: 213
Study 18774895 — intervention group
Group type: COMPARATOR
Intervention: General health control group
Number of subjects: 213
Study 16025971 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined internal-external therapy of TCM (internal administering of Chinese recipe and external applying of Fuxiong plaster)
Number of subjects: 817
Study 16025971 — intervention group
Group type: COMPARATOR
Intervention: Simulative placeboes (control group)
Number of subjects: 817
Study 16025971 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined internal-external therapy of TCM
Number of subjects: 817
Study 12844132 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg daily, 400 mg on day 1)
Number of subjects: 10
Study 12844132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11111141 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)‐monomethyl‐L‐arginine (LNMMA) infused intracoronarily at 4, 8 and 16 micromol/min
Number of subjects: 0
Study 11111141 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)‐monomethyl‐L‐arginine (LNMMA) infused intracoronarily
Number of subjects: 0
Study 8806006 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal salmon calcitonin (50 IU per dose)
Number of subjects: 120
Study 8806006 — intervention group
Group type: COMPARATOR
Intervention: Placebo (excipient only)
Number of subjects: 120
Study 8806006 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (salmon calcitonin and placebo)
Number of subjects: 120
Study 1282615 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine at a dose of 20 mg daily for 4 weeks
Number of subjects: 32
Study 1282615 — intervention group
Group type: COMPARATOR
Intervention: Beta-acetyldigoxin at a dose of 0.3 mg daily for 4 weeks
Number of subjects: 32
Study 6360334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavity irradiation
Number of subjects: 105
Study 6360334 — intervention group
Group type: COMPARATOR
Intervention: External beam irradiation
Number of subjects: 105
Study 31016819 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal podalic version
Number of subjects: 150
Study 31016819 — intervention group
Group type: COMPARATOR
Intervention: Short curved forceps
Number of subjects: 150
Study 31016819 — intervention group
Group type: COMPARATOR
Intervention: Vacuum
Number of subjects: 150
Study 29138241 — intervention group
Group type: EXPERIMENTAL
Intervention: GH (2 mg/day)
Number of subjects: 96
Study 29138241 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined GH (2 mg/day) and testosterone (250 mg/week)
Number of subjects: 96
Study 29138241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 29138241 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (250 mg/week)
Number of subjects: 96
Study 27079660 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALCAR) 3,000 mg/day orally for 2 months
Number of subjects: 20
Study 27079660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 24394686 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol syrup (5 g, 3 times per day)
Number of subjects: 326
Study 24394686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 22440372 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane Cristália®
Number of subjects: 130
Study 22440372 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane Abbott®
Number of subjects: 130
Study 19616743 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose radiotherapy (HDRT)
Number of subjects: 2812
Study 19616743 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose radiotherapy (CDRT)
Number of subjects: 2812
Study 17372833 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 17
Study 16376748 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary flow reserve (CFR) measurement determined by TTE
Number of subjects: 51
Study 16376748 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine stress echocardiography (DSE)
Number of subjects: 51
Study 12212692 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative NSVT patients
Number of subjects: 228
Study 12212692 — intervention group
Group type: COMPARATOR
Intervention: Nonpostoperative NSVT patients
Number of subjects: 228
Study 12212692 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative NSVT identified early (<10 days)
Number of subjects: 228
Study 12212692 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative NSVT identified late (10-30 days)
Number of subjects: 228
Study 9796348 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion behavior
Number of subjects: 397
Study 9796348 — intervention group
Group type: EXPERIMENTAL
Intervention: Social activities participation
Number of subjects: 397
Study 9796348 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical examinations frequency
Number of subjects: 397
Study 9796348 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation for health promotion
Number of subjects: 397
Study 9796348 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire to enjoy activities
Number of subjects: 397
Study 8719263 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (0.29 mg kg‐1)
Number of subjects: 8
Study 8719263 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.28 mg kg‐1)
Number of subjects: 8
Study 8719263 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 8
Study 8719263 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilt
Number of subjects: 8
Study 2136577 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration trials (2.5 seconds application of a vibrator to the maternal abdomen)
Number of subjects: 36
Study 2136577 — intervention group
Group type: COMPARATOR
Intervention: No-stimulus control trials
Number of subjects: 36
Study 773081 — intervention group
Group type: EXPERIMENTAL
Intervention: Inderal 40 mg q.i.d.
Number of subjects: 20
Study 773081 — intervention group
Group type: EXPERIMENTAL
Intervention: d-propranolol 40 mg q.i.d.
Number of subjects: 20
Study 773081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 773081 — intervention group
Group type: EXPERIMENTAL
Intervention: Inderal
Number of subjects: 20
Study 30201446 — intervention group
Group type: EXPERIMENTAL
Intervention: Training attachment behaviors to pregnant women (6 sessions of 90-min classes)
Number of subjects: 190
Study 30201446 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 190
Study 28224720 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine bromide (3 × 60 mg/day for 14 days)
Number of subjects: 13
Study 28224720 — intervention group
Group type: COMPARATOR
Intervention: Fludrocortisone (1 × 0.2 mg/day for 14 days)
Number of subjects: 13
Study 26429126 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-compliant balloon
Number of subjects: 50
Study 26429126 — intervention group
Group type: COMPARATOR
Intervention: Other types of balloons
Number of subjects: 50
Study 22782640 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab with isoniazid for latent TB treatment
Number of subjects: 2210
Study 22782640 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab without isoniazid
Number of subjects: 2210
Study 22782640 — intervention group
Group type: COMPARATOR
Intervention: Placebo and golimumab groups
Number of subjects: 2210
Study 22087637 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 100
Study 22087637 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (FENO)
Number of subjects: 100
Study 22087637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe plus Fenofibrate (EZE+FENO)
Number of subjects: 100
Study 22087637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin plus Fenofibrate (EZE/SIMVA+FENO)
Number of subjects: 100
Study 19221912 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing with a novice therapist in addition to treatment as usual (n=22)
Number of subjects: 47
Study 19221912 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual alone (n=25)
Number of subjects: 47
Study 16323128 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PRO 2000 gel
Number of subjects: 0
Study 16323128 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study 12204862 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing room air during symptom-limited maximum cycle exercise
Number of subjects: 20
Study 12204862 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxic breathing at rest
Number of subjects: 20
Study 12204862 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 20
Study 11279973 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual pulsing electromagnetic fields
Number of subjects: 42
Study 11279973 — intervention group
Group type: COMPARATOR
Intervention: Placebo pulsing electromagnetic fields
Number of subjects: 42
Study 11279973 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual pulsing electromagnetic fields (additional exposure)
Number of subjects: 42
Study 11279973 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual pulsing electromagnetic fields (no additional exposure)
Number of subjects: 42
Study 11279973 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (after additional exposure)
Number of subjects: 42
Study 8727016 — intervention group
Group type: EXPERIMENTAL
Intervention: Malleoloc ankle joint orthosis
Number of subjects: 12
Study 1764954 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 micrograms once-daily
Number of subjects: 342
Study 1764954 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 200 micrograms twice-daily
Number of subjects: 342
Study 1764954 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 342
Study 6859504 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lignocaine
Number of subjects: 70
Study 6859504 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 70
Study 6859504 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lignocaine + morphine sulphate 4 mg
Number of subjects: 70
Study 6859504 — intervention group
Group type: EXPERIMENTAL
Intervention: normal saline + morphine sulphate 4 mg
Number of subjects: 70
Study 6859504 — intervention group
Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 70
Study 30816729 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual perspective message (false balance condition)
Number of subjects: 0
Study 30816729 — intervention group
Group type: EXPERIMENTAL
Intervention: Provaccine messages
Number of subjects: 0
Study 30816729 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to online comments questioning HPV vaccination
Number of subjects: 0
Study 27591991 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg/day from day 1 for five consecutive days
Number of subjects: 100
Study 27591991 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron and dexamethasone in approved therapeutic dose from day 1 of chemotherapy
Number of subjects: 100
Study 26216550 — intervention group
Group type: EXPERIMENTAL
Intervention: LED phototherapy applied to one side of the dental arch
Number of subjects: 11
Study 26216550 — intervention group
Group type: COMPARATOR
Intervention: Control side (no LED phototherapy)
Number of subjects: 11
Study 24368354 — intervention group
Group type: EXPERIMENTAL
Intervention: LTTE performed (LTTEp)
Number of subjects: 215
Study 24368354 — intervention group
Group type: COMPARATOR
Intervention: non-LTTE
Number of subjects: 215
Study 24368354 — intervention group
Group type: EXPERIMENTAL
Intervention: LTTE performed (LTTEp) in traumatic brain injury patients
Number of subjects: 215
Study 24368354 — intervention group
Group type: COMPARATOR
Intervention: non-LTTE in traumatic brain injury patients
Number of subjects: 215
Study 22649526 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet-delivered cognitive behavior therapy (ICBT)
Number of subjects: 204
Study 22649526 — intervention group
Group type: COMPARATOR
Intervention: Moderated online discussion forum only (control)
Number of subjects: 204
Study 22649526 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist experience (experienced vs inexperienced)
Number of subjects: 204
Study 19687128 — intervention group
Group type: EXPERIMENTAL
Intervention: standard treatment plus applied behavioral analysis (N=32)
Number of subjects: 63
Study 19687128 — intervention group
Group type: COMPARATOR
Intervention: standard treatment only (N=31)
Number of subjects: 63
Study 17300303 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ml of 20% human albumin solution administered over 120 seconds
Number of subjects: 28
Study 17300303 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of furosemide intravenously along with albumin
Number of subjects: 28
Study 15067419 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavasept (polyhexamethylenbiguanid) 1.25%
Number of subjects: 29
Study 15067419 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-iodine
Number of subjects: 29
Study 15067419 — intervention group
Group type: COMPARATOR
Intervention: Ringer's solution
Number of subjects: 29
Study 15067419 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavasept
Number of subjects: 29
Study 15067419 — intervention group
Group type: EXPERIMENTAL
Intervention: All solutions tested
Number of subjects: 29
Study 11199951 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone with cognitive behavioral therapy
Number of subjects: 131
Study 11199951 — intervention group
Group type: COMPARATOR
Intervention: Placebo with cognitive behavioral therapy
Number of subjects: 131
Study 11199951 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 131
Study 9894384 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 9894384 — intervention group
Group type: COMPARATOR
Intervention: Conventional beta-blockers
Number of subjects: 0
Study 8538382 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplemented with 0.36% DHA (fish oil and evening primrose oil)
Number of subjects: 0
Study 8538382 — intervention group
Group type: COMPARATOR
Intervention: Placebo formula
Number of subjects: 0
Study 8538382 — intervention group
Group type: COMPARATOR
Intervention: Breast feeding
Number of subjects: 0
Study 8538382 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplemented with FO+EPO
Number of subjects: 0
Study 8538382 — intervention group
Group type: COMPARATOR
Intervention: Breast feeding and placebo formula
Number of subjects: 0
Study 2806133 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 108
Study 2806133 — intervention group
Group type: COMPARATOR
Intervention: Injection Sclerotherapy
Number of subjects: 108
Study 788820 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g ascorbic acid per day
Number of subjects: 688
Study 788820 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 688
Study 30741103 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Story Memory Technique (mSMT) training, twice per week for 5 weeks
Number of subjects: 30
Study 30741103 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (non-training-oriented tasks)
Number of subjects: 30
Study 31289068 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid suspension (intervention)
Number of subjects: 550
Study 31289068 — intervention group
Group type: COMPARATOR
Intervention: Intravenous therapy for another 5 days (control)
Number of subjects: 550
Study 27302626 — intervention group
Group type: EXPERIMENTAL
Intervention: RBCs stored 1‐10 days
Number of subjects: 147
Study 27302626 — intervention group
Group type: COMPARATOR
Intervention: RBCs stored 25‐35 days
Number of subjects: 147
Study 25952047 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment tool for infection control
Number of subjects: 60
Study 25952047 — intervention group
Group type: COMPARATOR
Intervention: Normal practices (Control)
Number of subjects: 60